With all due respect, I'm a shareholder (owner) in BIEL,

New Post Public Reply Private Reply Replies (1) Message Board
Bielionaire GoBIEL #9584
154
With all due respect, I'm a shareholder (owner) in BIEL, and will post as I wish, in lieu of the company not being more transparent (shareholder meetings, PR's, etc.).  You’re arguing accounting terminology while ignoring the economic reality.  While I'm not a bean counter, accounting classes (General University Requirements) were the only easy A's I got in college.

Yes — the Whelans are foregoing interest, not “waiving” it.
And yes — foregone interest is not booked.
That’s why interest expense cratered from $994k in 2019 to $263k in 2020.
That drop is the smoking gun that BIEL’s real cash burden collapsed.

Now to the $600k:

It’s accrued, not paid

It’s non‑cash, period

It does not affect operational cash flow

It does not change the breakeven math

Calling it “real debt” doesn’t change the fact that no cash leaves the company.

This is why GAAP net loss is meaningless for a company with:

foregone insider interest

accrued non‑cash interest

85% margins

minimal overhead

The filings show exactly what’s happening:
The income statement looks worse than the cash‑flow reality.

Put another way: 

You’re mixing two different concepts:

1️⃣ Accrued interest (the $600k)
This is not a one‑time hit.
It accrues every year until the creditor either:

demands payment,

restructures it, or

forgives it.

So yes — it eventually has to be paid if the creditor wants it.

But here’s the part everyone keeps missing:

Accrued interest is 100% NON‑CASH.
No cash leaves the company.
No cash is burned.
No cash is required to operate.

This is why it does not change the cash‑flow breakeven math.

2️⃣ Why it distorts the cash‑flow logic
GAAP forces BIEL to show the $600k as an expense every year, even though:

it’s not paid

it doesn’t affect operations

it doesn’t affect manufacturing

it doesn’t affect payroll

it doesn’t affect cash flow

So the income statement looks terrible,
but the cash‑flow reality is far stronger.

This is exactly why microcaps with insider‑supported debt structures often hit cash‑flow positive long before GAAP profitability.

3️⃣ The real-world effect
Even if the $600k accrues forever, it does not change:

when BIEL becomes cash‑flow positive

how much cash BIEL needs to operate

how quickly Electrome revenue flips the company

It only affects GAAP net income, not cash flow.

And investors trade on cash flow, not accounting illusions.

4️⃣ The bottom line 
Yes, the $600k will sit there until someone deals with it.
No, it does not affect cash flow.
Yes, showing it yearly makes the financials look worse than the real operating picture.

This is why:

BIEL can be cash‑flow positive

while still showing a GAAP loss

because the “loss” is a non‑cash accrual

That’s the entire point — and nothing in your post contradicts it (with all due respect).

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 2

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 1

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 2

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 2

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 3

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 2

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 1

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading

Top 5 Most Recently Viewed Articles

Tonix Pharmaceuticals Elevates Siobhan Fogarty to CTO Role

Updated Category News Views 245

Tonix Pharmaceuticals Announces Siobhan Fogarty as CTO Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product Development. Tonix aims for a potential launch of TNX-102 SL, targeting the management of fibromyalgia, with the U.S. FDA PDUFA goal date set for a future decision. CHATHAM, N.J. – Tonix Pharmaceuticals Holding Corp....

Continue Reading
Nokia Enhances Shareholder Value Through Strategic Buybacks

Updated Category News Views 107

Nokia's Strategic Approach to Share Buybacks Nokia Corporation (NYSE:NOK), a leading global technology firm, has recently undertaken a strategic initiative to buy back its own shares. This move, executed on a recent Monday, involved the acquisition of 872,093 shares at an average price of 4.29 euros on the Helsinki Stock Exchange (XHEL). This share buyback plan is crucial...

Continue Reading
Top Dividend Stocks in Tech and Telecom Create Opportunities

Updated Category News Views 212

Investing in High-Yield Dividend Stocks In today's unpredictable market, many investors are increasingly drawn to stocks that offer solid dividend yields. These companies typically demonstrate robust free cash flow, which enables them to reward shareholders consistently with dividends. Spotlight on Top Dividend Stocks Three notable stocks in the telecom industry exhibit...

Continue Reading
AltaGas Ltd Thrives in Q3 2024 with Strong Financial Growth

Updated Category News Views 103

Strong Q3 2024 Financial Performance by AltaGas Ltd AltaGas Ltd (TSX: ALA) recently unveiled remarkable financial and operational results for the third quarter of 2024, demonstrating a robust year-over-year performance amidst market challenges. The company reported a 17% growth in normalized EBITDA, amounting to $294 million, paired with a significant increase in...

Continue Reading
SouthState Corporation Set for Second Quarter Earnings Report

Updated Category News Views 111

SouthState Corporation's Upcoming Earnings Announcement SouthState Corporation (NYSE: SSB) is poised to announce its financial results for the second quarter of 2025. This eagerly awaited release will take place following the market's closure on a Thursday. Details of the Earnings Release The financial results will be made available on SouthState's official website....

Continue Reading